Marshall Wace North America »

Ultragenyx Pharmaceutical shares owned by Marshall Wace North America

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Marshall Wace North America from 13F filings

Historical chart of Marshall Wace North America investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Marshall Wace North America consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Marshall Wace North America

Quarter filed Position value Share count Share price at filing
2021-09-30 $19M 206k 90.19
2021-06-30 $12M 131k 95.34
2020-12-31 $715k 5.2k 138.57
2018-09-30 $245k 3.2k 76.28
2017-12-31 $587k 13k 46.40

More positions owned by Marshall Wace North America

Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc-c Common Stock (GOOG)
Alphabet Inc-a Common Stock (GOOGL)
Meta Platforms-a Common Stock (META)
Thermo Fisher Common Stock (TMO)
Apple Common Stock (AAPL)
Zoetis Common Stock (ZTS)
Netflix Common Stock (NFLX)
Uber Technologie Common Stock (UBER)
Boston Scientifc Common Stock (BSX)
Adobe Common Stock (ADBE)
Expedia Group In Common Stock (EXPE)
Steris Common Stock (STE)
Unitedhealth Grp Common Stock (UNH)

View all positions for Marshall Wace North America

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
BlackRock
Sands Capital Management
T. Rowe Price Associates
State Street Corporation
ClearBridge Advisors
Federated Investors
Suvretta Capital Management
Rock Springs Capital Management
Deutsche Bank Aktiengesellschaft
Invesco
Baker Bros. Advisors
Geode Capital Management
Alliancebernstein

View all funds holding Ultragenyx Pharmaceutical